References
- Tuomisto AE, Makinen MJ, Vayrynen JP. Systemic inflammation in colorectal cancer: underlying factors, effects, and prognostic significance. World J Gastroenterol. 2019;25(31):4383–404. doi:https://doi.org/10.3748/wjg.v25.i31.4383
- Haram A, Boland MR, Kelly ME, Bolger JC, Waldron RM, Kerin MJ. The prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review. J Surg Oncol. 2017;115(4):470–9. doi:https://doi.org/10.1002/jso.24523
- Terzic J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology. 2010;138(6):2101–14 e5. doi:https://doi.org/10.1053/j.gastro.2010.01.058
- Gunawardene A, Dennett E, Larsen P. Prognostic value of multiple cytokine analysis in colorectal cancer: a systematic review. J Gastrointest Oncol. 2019;10(1):134–43. doi:https://doi.org/10.21037/jgo.2018.07.11
- Sun L, Hu S, Yu L, Guo C, Sun L, Yang Z, Qi J, Ran Y. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis. Int J Cancer. 2016;138(11):2724–31. doi:https://doi.org/10.1002/ijc.29993
- Gunter MJ, Stolzenberg-Solomon R, Cross AJ, Leitzmann MF, Weinstein S, Wood RJ, Virtamo J, Taylor PR, Albanes D, Sinha R, et al. A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res. 2006;66(4):2483–7. doi:https://doi.org/10.1158/0008-5472.CAN-05-3631
- Yan G, Liu T, Yin L, Kang Z, Wang L. Levels of peripheral Th17 cells and serum Th17-related cytokines in patients with colorectal cancer: a meta-analysis. Cell Mol Biol (Noisy-le-Grand). 2018;64(6):94–102. doi:https://doi.org/10.14715/cmb/2018.64.6.16
- Abtahi S, Davani F, Mojtahedi Z, Hosseini SV, Bananzadeh A, Ghaderi A. Dual association of serum interleukin-10 levels with colorectal cancer. J Cancer Res Ther. 2017;13(2):252–6. doi:https://doi.org/10.4103/0973-1482.199448
- Chen X-L, Chen Z-Q, Zhu S-L, Liu T-W, Wen Y, Su Y-S, Xi X-J, Hu Y, Lian L, Liu F-B, et al. Prognostic value of transforming growth factor-beta in patients with colorectal cancer who undergo surgery: a meta-analysis. BMC Cancer. 2017;17(1):240: doi:https://doi.org/10.1186/s12885-017-3215-7
- Väyrynen JP, Kantola T, Väyrynen SA, Klintrup K, Bloigu R, Karhu T, Mäkelä J, Herzig K-H, Karttunen TJ, Tuomisto A, et al. The relationships between serum cytokine levels and tumor infiltrating immune cells and their clinical significance in colorectal cancer. Int J Cancer. 2016;139(1):112–21. : doi:https://doi.org/10.1002/ijc.30040
- Chen Z-Y, He W-Z, Peng L-X, Jia W-H, Guo R-P, Xia L-P, Qian C-N. A prognostic classifier consisting of 17 circulating cytokines is a novel predictor of overall survival for metastatic colorectal cancer patients. Int J Cancer. 2015;136(3):584–92. doi:https://doi.org/10.1002/ijc.29017
- Chen Z-Y, Raghav K, Lieu CH, Jiang Z-Q, Eng C, Vauthey J-N, Chang GJ, Qiao W, Morris J, Hong D, et al. Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer. Br J Cancer. 2015;112(6):1088–97. : doi:https://doi.org/10.1038/bjc.2015.61
- McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39(5):534–40. doi:https://doi.org/10.1016/j.ctrv.2012.08.003
- Kim S, McClave SA, Martindale RG, Miller KR, Hurt RT. Hypoalbuminemia and clinical outcomes: what is the mechanism behind the relationship?Am Surg. 2017;83(11):1220–7. doi:https://doi.org/10.1177/000313481708301123
- Goyal A, Terry MB, Jin Z, Siegel AB. C-reactive protein and colorectal cancer mortality in U.S. adults. Cancer Epidemiol Biomarkers Prev. 2014;23(8):1609–18. doi:https://doi.org/10.1158/1055-9965.EPI-13-0577
- Lai C-C, You J-F, Yeh C-Y, Chen J-S, Tang R, Wang J-Y, Chin C-C. Low preoperative serum albumin in colon cancer: a risk factor for poor outcome. Int J Colorectal Dis. 2011;26(4):473–81. doi:https://doi.org/10.1007/s00384-010-1113-4
- Nozoe T, Mori E, Takahashi I, Ezaki T. Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma. Surg Today. 2008;38(7):597–602. doi:https://doi.org/10.1007/s00595-007-3680-8
- Fan Y, Xiang S, Dai Z, Zou C, Wang X, Gao Z. Prognostic significance of C-reactive protein to albumin ratio in colorectal cancer patients: a meta-analysis. Int J Colorectal Dis. 2019;34(6):1105–11. doi:https://doi.org/10.1007/s00384-019-03299-x
- Väyrynen JP, Väyrynen SA, Sirniö P, Minkkinen I, Klintrup K, Karhu T, Mäkelä J, Herzig K-H, Karttunen TJ, Tuomisto A, et al. Platelet count, aspirin use, and characteristics of host inflammatory responses in colorectal cancer. J Transl Med. 2019;17(1):199. : doi:https://doi.org/10.1186/s12967-019-1950-z
- Haruki K, Shiba H, Horiuchi T, Sakamoto T, Gocho T, Fujiwara Y, Furukawa K, Misawa T, Yanaga K. Impact of the C-reactive protein to albumin ratio on long-term outcomes after hepatic resection for colorectal liver metastases. Am J Surg. 2017;214(4):752–6. doi:https://doi.org/10.1016/j.amjsurg.2017.02.001
- Luvián‐Morales J, González‐Trejo S, Carrillo JF, Herrera‐Goepfert R, Aiello‐Crocifoglio V, Gallardo‐Rincón D, Ochoa‐Carrillo FJ, Oñate‐Ocaña LF. Association of the prognostic nutritional index and overall survival in patients with colorectal cancer: a STROBE compliant retrospective cohort study. Cancer Med. 2019;8(7):3379–88. doi:https://doi.org/10.1002/cam4.2212
- Hung H-Y, Chen J-S, Yeh CY, Changchien C-R, Tang R, Hsieh P-S, Tasi W-S, You J-F, You Y-T, Fan C-W, et al. Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy. Int J Colorectal Dis. 2011;26(8):1059–65. : doi:https://doi.org/10.1007/s00384-011-1192-x
- Chang P-H, Hsieh JC-H, Yeh K-Y, Chen EY-C, Yang S-W, Huang J-S, Lai C-H, Wu T-H, Huang Y-M, Chang Y-S, et al. Prognostic nutritional index relevance in chemoradiotherapy for advanced oral cavity, oropharyngeal and hypopharyngeal cancer. Asia Pac J Clin Nutr. 2018;27(5):996–1001. doi:https://doi.org/10.6133/apjcn.032018.04
- Bohlius J, Weingart O, Trelle S, Engert A. Cancer-related anemia and recombinant human erythropoietin-an updated overview. Nat Clin Pract Oncol. 2006;3(3):152–64. doi:https://doi.org/10.1038/ncponc0451
- Araki K, Ito Y, Fukada I, Kobayashi K, Miyagawa Y, Imamura M, Kira A, Takatsuka Y, Egawa C, Suwa H, et al. Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel. BMC Cancer. 2018;18(1):982. doi:https://doi.org/10.1186/s12885-018-4888-2
- Pan YP, Chang PH, Fan CW, Tseng WK, Huang JS, et al. Relationship between pre-treatment nutritional status, serum glutamine, arginine levels and clinicopathological features in Taiwan colorectal cancer patients. Asia Pac J Clin Nutr. 2015;24:598–604.
- Ghuman S, Van Hemelrijck M, Garmo H, Holmberg L, Malmström H, Lambe M, Hammar N, Walldius G, Jungner I, Wulaningsih W, et al. Serum inflammatory markers and colorectal cancer risk and survival. Br J Cancer. 2017;116(10):1358–65. : doi:https://doi.org/10.1038/bjc.2017.96
- Park JW, Chang HJ, Yeo HY, Han N, Kim BC, Kong S-Y, Kim J, Oh JH. The relationships between systemic cytokine profiles and inflammatory markers in colorectal cancer and the prognostic significance of these parameters. Br J Cancer. 2020;123(4):610–8. doi:https://doi.org/10.1038/s41416-020-0924-5
- Templeton AJ, McNamara MG, Seruga B, Vera-Badillo FE, Aneja P, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106:dju124.
- Tominaga T, Nonaka T, Sumida Y, Hidaka S, Sawai T, Nagayasu T. The C-reactive protein to albumin ratio as a predictor of severe side effects of adjuvant chemotherapy in stage III colorectal cancer patients. PLoS One. 2016;11(12):e0167967. doi:https://doi.org/10.1371/journal.pone.0167967
- Tokunaga R, Sakamoto Y, Nakagawa S, Miyamoto Y, Yoshida N, Oki E, Watanabe M, Baba H. Prognostic nutritional index predicts severe complications, recurrence, and poor prognosis in patients with colorectal cancer undergoing primary tumor resection. Dis Colon Rectum. 2015;58(11):1048–57. doi:https://doi.org/10.1097/DCR.0000000000000458
- Zhou Z-Q, Pang S, Yu X-C, Xue Q, Jiang H-Y, Liang X-J, Liu L. Predictive values of postoperative and dynamic changes of inflammation indexes in survival of patients with resected colorectal cancer. Curr Med Sci. 2018;38(5):798–808. doi:https://doi.org/10.1007/s11596-018-1946-6
- Ni X, Wu P, Wu J, Ji M, Shao Y, et al. C-reactive protein/albumin ratio as a predictor of survival of metastatic colorectal cancer patients receiving chemotherapy. Int J Clin Exp Pathol. 2016;9:5525–34.
- Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Shibuya N, Kubota K. Clinical significance of the C-reactive protein to albumin ratio for survival after surgery for colorectal cancer. Ann Surg Oncol. 2016;23(3):900–7. doi:https://doi.org/10.1245/s10434-015-4948-7
- Sharma R, Zucknick M, London R, Kacevska M, Liddle C, Clarke SJ. Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancer. Clin Colorectal Cancer. 2008;7(5):331–7. doi:https://doi.org/10.3816/CCC.2008.n.044
- Pine JK, Morris E, Hutchins GG, West NP, Jayne DG, Quirke P, Prasad KR. Systemic neutrophil-to-lymphocyte ratio in colorectal cancer: the relationship to patient survival, tumour biology and local lymphocytic response to tumour. Br J Cancer. 2015;113(2):204–11. doi:https://doi.org/10.1038/bjc.2015.87
- Sarris AH, Kliche K-O, Pethambaram P, Preti A, Tucker S, Jackow C, Messina O, Pugh W, Hagemeister FB, McLaughlin P, et al. Interleukin-10 levels are often elevated in serum of adults with Hodgkin’s disease and are associated with inferior failure-free survival. Ann Oncol. 1999;10(4):433–40. : doi:https://doi.org/10.1023/A:1008301602785
- Mold C, Rodriguez W, Rodic-Polic B, Du Clos TW. C-reactive protein mediates protection from lipopolysaccharide through interactions with Fc gamma R. J Immunol. 2002;169(12):7019–25. doi:https://doi.org/10.4049/jimmunol.169.12.7019
- Zhang Z, Chen A, Xie F, Li X, Hu G, Lin G. Low prognostic nutrition index predicts poorer quality of life in late-stage lung cancer. Ann Palliat Med. 2020;9(6):3976–84. doi:https://doi.org/10.21037/apm-20-1892
- Go S-I, Park S, Kang MH, Kim H-G, Kim HR, Lee G-W. Clinical impact of prognostic nutritional index in diffuse large B cell lymphoma. Ann Hematol. 2019;98(2):401–11. doi:https://doi.org/10.1007/s00277-018-3540-1
- Porporato PE. Understanding cachexia as a cancer metabolism syndrome. Oncogenesis. 2016;5:e200. doi:https://doi.org/10.1038/oncsis.2016.3
- Zhang A, Xiong Y, Xu F, Wang Z, Ma J, Zhao N, Hu T, Yi J, Zhou Y, Luan X, et al. IL-1β enhances human placenta-derived mesenchymal stromal cells ability to mediate Th1/Th2 and Th1/CD4 + IL-10+ T cell balance and regulates its adhesion, proliferation and migration via PD-L1 . Cell Immunol. 2020;352:104113: doi:https://doi.org/10.1016/j.cellimm.2020.104113
- Zhao T-z, Xia Y-z, Li L, Li J, Zhu G, Chen S, Feng H, Lin J-k. Bovine serum albumin promotes IL-1beta and TNF-alpha secretion by N9 microglial cells. Neurol Sci. 2009;30(5):379–83. doi:https://doi.org/10.1007/s10072-009-0123-x
- Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005;201(2):233–40. doi:https://doi.org/10.1084/jem.20041257
- Morrison PJ, Ballantyne SJ, Kullberg MC. Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity. Immunology. 2011;133(4):397–408. doi:https://doi.org/10.1111/j.1365-2567.2011.03454.x
- Stark MA, Huo Y, Burcin TL, Morris MA, Olson TS, Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity. 2005;22(3):285–94. doi:https://doi.org/10.1016/j.immuni.2005.01.011
- Jessup JM, Laguinge L, Lin S, Samara R, Aufman K, Battle P, Frantz M, Edmiston KH, Thomas P. Carcinoembryonic antigen induction of IL-10 and IL-6 inhibits hepatic ischemic/reperfusion injury to colorectal carcinoma cells. Int J Cancer. 2004;111(3):332–7. doi:https://doi.org/10.1002/ijc.20264
- Calder PC. Immunonutrition. BMJ. 2003;327(7407):117–8. doi:https://doi.org/10.1136/bmj.327.7407.117
- Freitas RDS, Campos MM. Protective effects of omega-3 fatty acids in cancer-related complications. Nutrients. 2019;11(5):945. doi:https://doi.org/10.3390/nu11050945